References
- Aittomaki K, Lucena JLD and Pakarinen P. 1995. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic hypogonadism. Cell. 82:959-968. https://doi.org/10.1016/0092-8674(95)90275-9
- Bae F, Pescovitz OH and Steinmetz R. 2009. No activating mutations of FSH receptor in four children with ovarian juvenile granulosa cells tumors and the association of these tumors with central precocious puberty. J Pediatr Adolesc Gyneco. 22:173-179. https://doi.org/10.1016/j.jpag.2008.10.003
- Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, Milgrom E, Kuttenn F and Misrahi M. 1998. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest. 102:1352-1359. https://doi.org/10.1172/JCI3795
- Bramble MS, Goldstein EH, Lipson A, Ngun T, Eskin A, Gosschalk JE, Roach L, Vashist N, Barseghyan H, Lee E, Arboleda VA, Vaiman D, Yuksel Z, Fellous M and Vilain E. 2016. A novel follicle-stimulating hormone receptor mutation causing primary ovarian failure: a fertility application of whole exome sequencing. Human Reproduction. 31:905-914. https://doi.org/10.1093/humrep/dew025
- Byambarachaa M, Kim DJ, Kang MH and Min KS. 2018a. Site specificity of eel luteinizing hormone N-linked oligosaccharides in signal transduction. Gen Comp Endocrinol. 268:50-56. https://doi.org/10.1016/j.ygcen.2018.07.015
- Byambarachaa M, Lee SY, Kim DJ, Kang MH and Min KS. 2018b. Signal transduction of eel luteinizing hormone receptor (eelLHR) and follicle stimulating hormone receptor (eelFSHR) by recombinant equine chorionic gonadotropin (rec-eCG) and native eCG. Dev Reprod. 22:55-63. https://doi.org/10.12717/DR.2018.22.1.055
- Fragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, Araujo LM, Lando VS, FrazzattoET, Mendonca BB and Villares SM. 1998. Activating mutation of the stimulatory G protein as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocinol Metab. 83:2074-2078.
- Ghezelayagh Z, Totonchi M, Zarei-Moradi S, Asadpour O, Maroufizadeh S, Eftekhari-Yazdi E, Gourabi H and Mohseni-Meybodi A. 2016. The impact of genetic variation and gene expression of the follicle-stimulating hormone receptor on ovarian reserve. Cell J. 19:620-626.
- Gromoll J, Simoni M, Nordhoff V, Behre HM, De Geyter C and Nieschlag E. 1995. Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol. 125:177-182. https://doi.org/10.1016/S0303-7207(96)03949-4
- Gromoll J, Simoni M and Nieschlag E. 1996. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spematogenesis in a hypophysectomized man. J Clin Endocrinol Metab. 81:1367-1370. https://doi.org/10.1210/jcem.81.4.8636335
- Katari S, Wood-Trageser MA, Jiang H, Kalynchuk E, Muzumdar R, Yatsenko SA and Rajkovic A. 2015. Novel inactivating mutation of the FSH receptor in two siblings of indian origin with premature ovarian failure. J Clin Endocrinol Metab. 100:2154-2157. https://doi.org/10.1210/jc.2015-1401
- Kim DJ, Park CW, Byambaragchaa M, Kim SK, Lee BI, Hwang HK, Myeong JL, Hong SM, Kang MH and Min KS. 2016a. Data on the characterization of follicle-stimulating hormone monoclonal antibodies and localization in Japanese eel pituitary. Data Brief. 8:404-410. https://doi.org/10.1016/j.dib.2016.05.069
- Kim DJ, Park CW, Kim DW, Park HK, Byambaragchaa M, Lee NS, Hong SM, Seo MY, Kang MH and Min KS. 2016b. Production and characterization of monoclonal antibodies against recombinant tethered follicle-stimulating hormone from Japanese eel anguilla japonica. Gen Comp Endocrinol. 233:8-15. https://doi.org/10.1016/j.ygcen.2016.04.030
- Kim JM, Munkhuu O, Byambaragchaa M, Lee BI, Kim SK, Kang MH, Kim DH and Min KS. 2019. Site-specific roles of Nlinked oligosaccharides in recombinant eel follicle-stimulating hormone for secretion and signal transduction. Gen Comp Endocrinol. 276: 37-44. https://doi.org/10.1016/j.ygcen.2019.03.003
- Laue L, Chan WY, Hsueh A, Kudo M, Hsu SY and Wu SM. 1995. Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. Proc Natl Acad Sci USA. 92:1906-1910. https://doi.org/10.1073/pnas.92.6.1906
-
Layman LC and McDonough PG. 2000. Mutations of follicle stimulating hormone-
${\beta}$ and its receptor in human and mouse: genotype/phenotype. Mol Cell Endocrinol. 161:9-17. https://doi.org/10.1016/S0303-7207(99)00217-8 - Lee SY, Byambaragchaa M, Kim JS, Seong HK, Kang MH and Min KS. 2017. Biochemical characterization of recombinant equine chorionic gonadotropin (rec-eCG), using CHO cells and pathHunter parental cells expressing equine luteinizing hormone/chorionic gonadotropin receptors (eLH/CGR). J Life Sci. 27:864-872. https://doi.org/10.5352/JLS.2017.27.8.864
- Liu H, Xu X, Han T, Yan L, Cheng L, Qin Y, Liu W, Zhao S and Chen Z. 2017. A novel homozygous mutation in the FSHR gene is causative for primary ovarian insufficiency. Fertility and Sterility. 108:1050-1055. https://doi.org/10.1016/j.fertnstert.2017.09.010
- Min KS, Hiyama T, Seong HH, Hattori N, Tanaka S and Shiota K. 2004. Biological activities of tethered equine chorionic gonadotropin (eCG) and its deglycosylated mutants. J Reprod Dev. 50:297-304. https://doi.org/10.1262/jrd.50.297
- Nakano R, Kitayama S and Yamato M. 1989. Localization of gonadotropin binding sites in human ovarian neoplasms. Am J Obstet Gynecol. 161:905. https://doi.org/10.1016/0002-9378(89)90749-7
- Simoni M, Gromoll J and Nieschlag E. 1997. The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocrine Reviews. 18:739-771. https://doi.org/10.1210/edrv.18.6.0320
- Simoni M and Nieschlag E. 1995. FSH in therapy: physiological basis, new preparations and clinical use. Reprod Med Rev. 4:163-177. https://doi.org/10.1017/S0962279900001150
- Stouffer RL, Grodin MS, Davis JR and Surwit EA. 1984. Investigation of binding sites for follicle-stimulating hormone and chorionic gonadotropin in human ovarian cnacers. J Clin Endocrinol Metab. 59:441-446. https://doi.org/10.1210/jcem-59-3-441
- Tapanainen JS, Aittomaki K, Min J, Vaskivuo T and Huhtaniemi IT. 1997. Men homozygous for an inactivating mutations of the follicle-stimulating hormone receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet. 15:205-206. https://doi.org/10.1038/ng0297-205